PRPF38B and neoplasm: This approach has identified a novel splice variant of a previously characterised protein called PRPF38B (Supplementary Figure 1) which appears to elicit specific immune responses in the tumour-bearing host and which, at the RNA level, is significantly overexpressed in a significant number of breast cancer tissues when compared to their matched normal counterparts.